WHAT THIS PAPER ADDS Characteristics of the carotid plaque in patients with carotid stensosis can identify those patients with relatively higher risk for stroke and help select patients who may benefit from intervention over medical treatment alone or vice versa. This review discusses the current role of two-dimensional and three-dimensional ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography in defining carotid plaque characteristics and in informing clinical practice. Most of these non-invasive imaging techniques have been discussed as single entity techniques. This paper puts the relative strengths and weaknesses of the different technical options in perspective in relation to clinical applicability.
INTRODUCTION
Cerebral embolism from atherosclerotic carotid plaque remains an important pathophysiological mechanism of ipsilateral stroke, and carotid endarterectomy (CEA) in recently symptomatic patients with a high-grade carotid artery stenosis significantly reduces the (recurrent) stroke risk.
The principle indication for carotid revascularisation is based on symptomatic status, timing, and degree of ipsilateral carotid artery stenosis. In symptomatic patients, with for example a single ocular symptom and smooth 70% carotid stenosis, the risk for recurrent stroke may be very low, and in these patients the benefit of revascularisation may be marginal. Alternatively, in asymptomatic patients the indication for revascularisation still remains a matter of debate, and current UK guidelines generally advocate a conservative approach in these patients, unless part of a clinical trial. 1 Overall in asymptomatic males, younger than 75 years, CEA compared with best medical treatment (BMT) significantly reduces the 10-year stroke risk. 2 However, based on clinical patient characteristics, selected subgroups of patients with asymptomatic carotid stenosis may benefit from carotid revascularisation. Increased systolic blood pressure, raised serum creatinine, smoking history, and a history of contralateral transient ischaemic attacks have been associated with an increased natural risk of ipsilateral cerebrovascular or retinal ischemic events. 3 However, these parameters are insufficient to fully balance the natural risk with procedural risk and additional anatomical and vessel wall-specific parameters are needed to ultimately assess the individual patient risk for future stroke and related benefit of revascularisation.
Research in carotid imaging has focused on identifying characteristics that determine the "vulnerable" or unstable carotid plaque making the patient at "high risk for future ipsilateral stroke". 4, 5 Several structural plaque characteristics are proposed that distinguish the "vulnerable" from the "non-vulnerable" plaque, which includes plaque ulceration, intraplaque haemorrhage (IPH), thin or ruptured fibrous cap (FC), lipid-rich necrotic core, and the presence of calcification. 6 Inflammation may also play a role in the development and progression of disease as well as identifying the vulnerable plaque. 7 A limitation of these studies on histological validation is the basis on post-endarterectomy specimens, and that they are mostly derived from symptomatic patients, with a relative long time interval between index event and CEA. 8 Identifying features of the vulnerable plaque in vivo may help select patients who benefit from intervention over medical treatment alone or vice versa. A variety of conventional and advanced in vivo imaging modalities including two-dimensional (2D) or three-dimensional (3D) ultrasound (US), computed tomography (CT), high-resolution magnetic resonance imaging (HRMRI), and nuclear imaging techniques such as positron emission tomography (PET) have been applied to identify plaque characteristics. Each technique and modality has been applied in observational studies to identify features of the carotid plaque, but it is unclear whether these newer techniques can be translated to, and impact on, daily clinical care, leading ultimately to patient benefit. This paper overviews the literature on currently available non-invasive imaging techniques to characterise the vulnerable carotid plaque with histology as the gold standard, and summarises the challenges and needs for the development of next-generation imaging tools to be of help in future clinical decision-making (Tables 1 and 2) .
ULTRASOUND

Current state
US is the modality of choice for initial evaluation and confirmation of carotid artery disease. US is used with highresolution B-mode imaging alone or in combination with colour Doppler flow. US is a widely available, low cost and low-risk tool, which is well tolerated by patients and thus ideal for screening for the presence of the atherosclerotic plaque. A disadvantage is that it relies on the operator's ability, and systemic haemodynamic and local anatomic factors, such as calcification and tortuosity of the carotid artery. Variable levels of interobserver agreement for Internal Carotid Artery Peak Systolic Velocity (ICA PSV) ranging from À25% to 43% between experienced technologists have been reported. 9 However, in the UK the Society of Vascular Technologists promote internal audit with duplicate scanning between technicians to standardise reporting.
The use of the grey-scale median (GSM), a computerised measurement of plaque echogenicity, aims to differentiate echogenic carotid plaques (associated with a fibrocalcified content [stable appearance]) from echolucent plaques (with a thin FC, a higher lipid or haemorrhagic content [unstable appearance]). Although a low GSM, reflecting an echolucent (unstable) lesion, has been associated with an increased risk of cerebrovascular events, 10 the use of different software and different applications for GSM measurement between research groups has resulted in a wide range of cut-off values for the definition of vulnerable plaque with no clear consensus or standardisation for routine practise.
11
Ulceration A focal depression, causing an irregular surface, suggests plaque ulceration. The most widely used criteria to define plaque ulceration are the presence of a recess of at least 2 mm deep and 2 mm long, a well-defined wall at its base and an area of reversed flow at the level of the recess. 12 Ultrasound may vary significantly in sensitivity (33e75%) and specificity (33e92%) for determining plaque ulceration and in many cases may reflect the lack of familiarity in looking for this feature. 13, 14 Intraplaque haemorrhage Haemorrhage can be found at the adventitial side of the arterial wall as neovascularisation or intraluminal as a thrombus, and incorporated in the plaque. 15 Causality is proposed by neovessel leakage or due to repeated plaque fissuring and formation of intraluminal thrombus that gets incorporated into the plaque. 16 Presence of thrombus or intraplaque haemorrhage leads to an echolucent lesion on US that is similar to a fatty core. Sensitivity and specificity for detection of intraluminal thrombus using conventional 2D US are accurate in the range of 80e90% and 80e91% respectively. 17, 18 This is in contrast to GSM findings and intraplaque haemorrhage (IPH) histology (r ¼ À.31 and p ¼ .07). 19 Neovascularisation itself can be detected by contrastenhanced US. Plaques with a higher contrast agent enhancement showed a greater neovascularisation at histology (grade 2 vs. grade 1 contrast enhancement: median vasa vasorum density 3.24 mm 2 vs. 1.82 mm 2 , respectively, p ¼ .005). 20 
Fibrous cap
The fibrous cap (FC) appears as an echogenic structure that displays stronger echoes than the overall plaque and blood. Thickness of the FC can be determined with a 73% sensitivity and 67% specificity using stratified GSM measurements. 21 Ultrasonic backscatter (IBS) was found to be lower in the thin FC compared with the thick FC. 22 
Lipid-rich core
Lipid appears echolucent and similar to IPH on ultrasound. The presence of lipid necrosis contributes to a heterogeneous pattern of the plaque. 23 The Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) study looked at the overarching feature of "juxtaluminal black area" to account for either IPH or a large fatty core, correlating this US feature with increased risk of stroke in an observational series. 24 The size of the lipid core seems critical for the stability of the plaque, the larger the pool the less stable the plaque. 25 Data on the ability to detect the lipid core are conflicting, using ultrasound (r ¼ .58; p ¼ .031) or computer-aided grey scale analysis (r ¼ .1; p ¼ .37).
26,27
Calcification Calcification appears hyperechogenic and assessment has been described by the mean pixel value, 28 the GSM, 10 and the pixel distribution. 26 All showed good correlation with histology, respectively r ¼ .8, p ¼ .002; r ¼ .30, p ¼ .07, and r ¼ .85, p ¼ .001. However, the studies were limited by a small sample size. Furthermore, acoustic shadowing of a heavily calcified plaque limits the assessment of severity of stenosis and other plaque characteristics.
Discussion and future directions
Ultrasound is a low-cost, low-risk tool, and well-tolerated by patients. However, it lacks the accuracy to reliably detect individual plaque components and characteristics. 13, 14, 27 Specifically, IPH and a fatty core are both ecolucent "black" areas. As is apparent from the abovenamed studies, several problems can be addressed: inter-and intraobserver variability, efficacy of standardised computerised assessments, and the limited assessment of a heavily calcified plaque due to acoustic shadowing. Research efforts are ongoing to overcome these limitations and to increase the clinical application of ultrasound.
3D imaging may show improved reproducibility and allows good visualisation of the luminal plaque surface and would therefore be of use in the detection of plaque ulceration. This technique detected carotid plaque ulceration more frequently than the 2D method (16.1% vs. 6.5% respectively). 29 As 3D US can capture all critical dimensions of the plaque, it has been used in volumetric measurements of the carotid plaque, showing observer variability in the range of 6e15%. 30, 31 Although 3D US seems promising, it remains a research tool as solid state 3D probes are in evolution and current techniques are time-consuming. Furthermore, data on the accuracy of 3D ultrasound plaque characterisation with histological validation are limited. 29, 32 COMPUTED TOMOGRAPHY
Current state
CT angiography (CTA) is a validated tool for the noninvasive assessment of degree of carotid artery stenosis. Where ultrasound lacks the ability to image high bifurcation and tortuous vessels, CTA is able to image from the aortic arch to the brain parenchyma. However, the radiation dosage, the need for intravenous contrast, and calcification artefacts are acknowledged drawbacks. Hounsfield units (HU) are used to describe radiodensity on a quantitive scale.
Ulceration
The presence of a plaque ulcer on CTA is defined as an intimal defect with extension of contrast material beyond the lumen into the surrounding plaque. The use of a multidetector CTA (MDCTA) detects ulceration with moderate to good sensitivity (60e94%) and specificity (70e99%) when compared with histology. 14, 33 Intraplaque haemorrhage IPH is associated with very low HU values (À17 HU to 31 HU). 32, 33 MDCTA was able to detect plaques complicated with haemorrhage with good sensitivity (100%) and moderate to good specificity (64% and 70%). 34, 35 A further study showed good correlation of CTA with histology for large haemorrhages. 36 
Fibrous cap
An intact FC is believed to be associated with low-risk plaque rupture, whereas a thin or fissured plaque is associated with high-risk plaque rupture. FC thickness may be measurable with a good correlation to histology, 36 and MDCTA observed an association between fissured FC and cerebrovascular symptoms. 37 However this study did not incorporate a histological analysis.
Lipid-rich core
A lipid core can be identifiable as hypodense region, with a median tissue density ranging from 25 HU to 32.6 HU. 36, 38 In vivo MDCT may assess good correlations of a large lipid core with histology. However, findings were limited to mildly calcified plaques. 38 
Calcification
CTA is a sensitive technique in the detection of calcification, which appears as a high-density structure in the plaque. The presence of calcification and quantification of calcification can be reliably detected with MDCT. A lower content of calcification was associated with a greater prevalence of neurological symptoms. 39 
Discussion and future directions
CT is considered to be the best imaging technique to identify calcification in the carotid plaque. 39 However, significant overlap in HU values between different components and the presence of calcification artefact limit its use in plaque analysis. Removal of bone and calcification pixels could potentially be a solution, but this is a time-consuming process and therefore exceeds practical limits in routine clinical work flow. Therefore, a program for automated removal of bone pixels from CTA data sets has been proposed. 40 In addition to plaque morphology and severity of stenosis, MDCT has the ability to quantify plaque volume, with a moderate interobserver variability. 41 Furthermore, plaque volume assessed by MDCT was correlated with severity of stenosis and cardiovascular risk factors. 42 There is increasing evidence that high shear stress plays an important role in the enhancement of plaque vulnerability. 43 However, little is known about the exact pathophysiological mechanism of shear stress in plaque progression. MDCTA 3D lumen geometry assessment may in the future contribute to the knowledge of various haemodynamic factors, such as sheared stress. 
44
MAGNETIC RESONANCE IMAGING
Current state
Because of its high soft-tissue contrast, high in-plane resolution, and high reproducibility, MRI has shown great potential in atherosclerotic plaque imaging with good sensitivity and specificity. Several human in vivo studies have shown the ability to detect vulnerable plaque characteristics on 1.5-Tesla MRI, whereas the diagnostic accuracy of 3-Tesla and 7-Tesla MRI in patients with high-grade stenosis is currently under investigation. 45, 46 Important disadvantages of MRI include its relative low availability and long procedure time. Furthermore, with the use of a clinical 1.5-Tesla scanner, it still remains a challenge to distinguish different intraplaque tissues from each other because of an inferior signal-to-noise ratio than scanners using a higher field magnet.
Ulceration
MRI can detect ulceration with moderate sensitivity using 3D time-of-flight (TOF), T1, proton density, T2, and contrastenhanced T1 sequences, 47 where it appears as a surface disruption on all contrast weightings. Adding longitudinal black-blood MR angiography increases the sensitivity and specificity of MRI to identify ulceration to 80% and 70% respectively. 48 
Intraplaque haemorrhage
MRI is of clinical value in detecting IPH and one of the most investigated plaque components in MRI analysis. IPH can be detected with a sensitivity of 82e97% and specificity of 74e100%. 45, 49 According to the age of thrombus, IPH appears hyperintense on T1-weigthed (T1W) and TOF images and hypointense on T2-weigthed (T2W) and proton density weighted images (fresh thrombus), hyperintense on all contrast weightings (recent thrombus) or hypointense on all contrast weightings (organised thrombus). 50 It is hard to distinguish IPH from a lipid-rich core (LRC) as the thrombus is often located in the necrotic core.
Fibrous cap
On MRI the FC appears as a juxtaluminal band, which is hypointense at TOF weightings and isointense at T1, T2, and proton density weightings. The absence of this band can indicate either a ruptured or a thin FC. Differentiation between the last two still remains a significant challenge. 45 However, a 3D multiple overlapping thin slab protocol may be capable of distinguishing the thick intact FC from the intact thin and ruptured FC. 50 
Lipid-rich core
An LRC can be detected on MRI with a sensitivity ranging from 82% to 100% and a specificity ranging from 40% to 100%. 49, 51, 52 On MRI, T1 sequences can identify an LRC, where it appears as a hyperintense area. Detection of an LRC slightly improves when IPH is not present. 52 Calcification Calcification can be detected by MRI with a sensitivity of 76e84% and specificity of 86e94%. It appears hypointense on all contrast images. 45, 49 Area measurement of calcification as a percentage of the vessel wall may be underestimated using histology as the reference. 51 Discussion and future directions Currently, MRI seems to have the most potential to identify vulnerable plaque components, as it benefits from high softtissue contrast and a high in-plane resolution. The aforementioned studies show that MRI can identify most described plaque characteristics with moderate to good agreement. 45, 48, 49, 51, 52 Despite sufficient evidence that MRI can provide useful information on plaque characteristics, there are potential barriers to its implementation as a routine risk stratification tool. Most importantly, its high cost and low availability, especially for 3-Tesla and 7-Tesla MRI.
Recently a 3D-based MRI technique has been proposed. This technique combines three 4-minute carotid plaque sequences (3D SNAP, T1W pre-and post contrast) in a short scanning time. 53, 54 Furthermore, there is a strong interest and ongoing research in potential labelled biomarkers that target specific molecules present in the "vulnerable" atherosclerotic lesion. Molecular MRI can be performed using iron oxide particles (USPIO) or other contrast agents that enhance specific molecules or cells, such as elastin, fibrin, or vascular cell adhesion molecule-1 and are of potential in identifying the "vulnerable" carotid plaque. 55 As previous analyses revealed that patients with silent cerebral ischaemic events are of high risk of future stroke, another potential area for future research may focus on the correlation between carotid plaque characteristics and cerebral damage. Compared with 1.5-Tesla and 3-Tesla, 7-Tesla MRI has proven to better visualise cerebral microbleeds and micro-infarcts. In symptomatic patients with high-grade stenosis, cerebral micro-infarcts detected by 7-Tesla MRI were correlated with the total cerebrovascular burden in the ipsilateral hemisphere. 56 Currently, the atherosclerotic plaque features derived from MRI wall imaging data are manually processed. Consequently, this is subject to inter-and intra-observer variability and an overall time-consuming process. Automated segmentation techniques have been developed to overcome these drawbacks. 44 
POSITION EMISSION TOMOGRAPHY
Current state
PET allows assessment of specific metabolic functions with tracers labelled with positron emitting radio-isotopes. 18 Fludeoxyglucose ( 18 FDG) is the most explored and established PET tracer for in vivo imaging of atherosclerosis. 18 FDG PET can probe plaque inflammation in vulnerable plaques directly. The disadvantage of PET is its limited spatial resolution (3e5 mm), which makes anatomic assignment for FDG uptake imprecise. This can be partially offset by coregistration of the PET images with CT or MRI acquired by hybrid scanner constructs, which are becoming more widely available (PET/CT and more recently PET/MRI). Non-specific uptake of tracer by surrounding tissues (e.g. FDG uptake in adjacent muscles and nodes) is also a hindrance.
Inflammation
A significant correlation was found between the FDG PET signal and macrophage staining from the corresponding histologic sections in 17 patients with severe carotid stenosis. 57 Several studies have reported on the association between FDG uptake and the risk of future events in both asymptomatic and symptomatic individuals. 57, 58 Furthermore, in recently symptomatic carotid stenosis FDG uptake in the ipsilateral carotid plaque was greater in patients with early recurrent stroke. 59 
Plaque morphology
In 50 patients with symptomatic carotid stenosis the correlation between plaque 18 FDG standard uptake values and CT/ MRI findings (lipid rich necrotic core, vessel wall, and fibrous tissue volume) was weak. 60 The correlations between CT and MRI findings were moderate to strong. LRNC and calcifications were significantly larger on CT, whereas measurements of fibrous tissue were significantly larger on MRI. 60 Plaque calcification, which is generally suggested to confer stability to the plaque, has also been found inversely related to PET and histological biomarkers of inflammation. 58 Discussion and future directions PET has the advantage over existing imaging techniques to target inflammation directly, using 18 FDG as radioactive tracer. 57 Because of its limited spatial resolution, it lacks anatomic precision and should therefore be combined with CT or MRI images. It is however a versatile technique with the potential to study other pathophysiological processes underpinning plaque evolution directly.
Currently, other molecular PET tracers are being studied in humans, for example 68 Ga-labelled somatostatin receptor probes as an alternative marker of inflammation and 18 Fsodium fluoride potentially for microcalcification, with some success. Tracers that probe lipid accumulation, proteolysis, neoangionesis, and thrombosis are also potentially promising. However, data are limited and only available from preclinical molecular imaging studies. 61 To facilitate the translation of promising PET tracers into the clinic setting, the co-registration of PET images with CT or MRI is of importance. Co-registration of MRI might be of additional benefit over CT as it better visualises the vessel wall.
Further information about molecular processes in the carotid plaque can be obtained by use of single photon emission computed tomography (SPECT). SPECT is similar to PET in detecting gamma radiation, but has the disadvantage of a two to three times lower spatial resolution. Radiolabeled SPECT tracers that are available for specific plaque vulnerability include 99m Tc-labelled oxidised low-density lipoprotein ( 99m Tc-LDL) accumulation and apoptosis ( 99m Tc-annexin-V) 62 
DISCUSSION
The current review summarises the current state and more importantly future directions in non-invasive imaging of vulnerable carotid plaque. US, CT, MRI, and PET are noninvasive imaging techniques that show promise for identifying vulnerable plaque characteristics beyond the degree of stenosis.
Although the aforementioned imaging parameters are promising, at present there is no single imaging technique that can clearly identify the vulnerable plaque. This is because (a) there is no single imaging modality that can detect all vulnerable plaque features, (b) plaque imaging is expensive, time-consuming, and requires a reviewer with advanced experience, and (c) prospective natural follow-up studies analysing the value of these imaging modalities for future cerebral events are limited. It is therefore important to realise that even if we could reliable identify ulceration, LRC, thin FC, and IPH as characteristics of the vulnerable plaque, at this stage there is not enough evidence that these patients indeed have a higher risk of stroke.
In order to provide more detailed morphological information about the carotid plaque, the more established imaging techniques, such as US, CT, and MRI need to be further improved. Furthermore, the development of functional molecular imaging techniques (PET and SPECT) and 3D US hold promise for the future. 29, 57 In addition to the non-invasive imaging techniques covered in this review, several invasive techniques, such as optical coherence tomography, intravascular ultrasound (IVUS), or combined IVUS with near infrared spectroscopy, are areas of ongoing plaque imaging research, but were beyond the scope of the current review. Furthermore, due to the large amount of studies, it was not feasible to report one parameter that describes the correlation between plaque imaging techniques and histology.
Comparison of potential imaging characteristics of the vulnerable plaque with histological analysis is essential to further develop these future techniques. Application of plaque imaging in ongoing or proposed prospective studies and multicentre trials in patients with asymptomatic and symptomatic carotid artery stenosis will tell us in the near future if and how we can guide treatment on an individual patient level.
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CONCLUSION
Currently available non-invasive imaging modalities for atherosclerotic carotid plaque offer the potential to identify specific vulnerable plaque components. MRI has the most potential, with good sensitivity and specificity for most plaque characteristics. However, currently there is no single imaging modality that can reliably identify the vulnerable plaque in relation to development of future stroke.
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